CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key Market Segments

1.3.1. List of key players profiled in the report:

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research

1.5. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. key findings

3.2.1. Top investment pockets

3.3. Top player positioning
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Global Increase in air pollution
3.4.1.2. Increase in population susceptible to indoor air pollutants
3.4.1.3. Increasing prevalence of COPD and asthma globally
3.4.1.4. Expected increase in adherence to smart inhalers
3.4.1.5. Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
3.4.1.6. Rising incidences of asthma cases

3.4.2. Restraints

3.4.2.1. Misusing data and data privacy
3.4.2.2. Resistance towards adoption of smart inhalers

3.4.3. Opportunities

3.4.3.1. Increased focus towards advanced treatment protocols
3.4.3.2. Significant unmet need in respiratory care
3.4.3.3. Opportunities in emerging economies
3.4.3.4. Impact analysis

CHAPTER 4: INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Wearable Asthma monitoring devices

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Smart Inhalers

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Inhalers

4.3.2.2. Market Size and Forecast
4.3.2.3. Key trends and opportunities

4.3.2.3.1. Dry Powdered Inhalers (DPIs)
4.3.2.3.2. Metered Dose Inhalers (MDI's)

4.3.2.1. Nebulizers

4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country

CHAPTER 5: INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Homecare

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Clinics

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key trends and opportunities
6.2.2. North America market size & forecast, by country

6.2.2.1. U.S. market size & forecast, by product
6.2.2.2. U.S. market size & forecast, by end user
6.2.2.3. Canada market size & forecast, by product
6.2.2.4. Canada market size & forecast, by end user
6.2.2.5. Mexico market size & forecast, by product
6.2.2.6. Mexico market size & forecast, by end user

6.2.3. North America market size & forecast, by product
6.2.4. North America market size & forecast, by end user

6.3. Europe

6.3.1. Key trends and opportunities
6.3.2. Europe market size & forecast for intelligent asthma monitoring devices market, by country

6.3.2.1. Germany market size & forecast, by product
6.3.2.2. Germany market size & forecast, by end user
6.3.2.3. France market size & forecast, by product
6.3.2.4. France market size & forecast, by end user
6.3.2.5. UK market size & forecast, by product
6.3.2.6. UK market size & forecast, by end user
6.3.2.7. Italy market size & forecast, by product
6.3.2.8. Italy market size & forecast, by end user
6.3.2.10. Rest of Europe market size & forecast, by product
6.3.2.11. Rest of Europe market size & forecast, by end user

6.3.3. Europe market size & forecast, by product
6.3.4. Europe market size & forecast, by end user

6.4. Asia-Pacific

6.4.1. Key trends and opportunities
6.4.2. Asia-Pacific market size & forecast, by country

6.4.2.1. Japan market size & forecast, by product
6.4.2.2. Japan market size & forecast, by end user
6.4.2.3. China market size & forecast, by product
6.4.2.4. China market size & forecast, by end user
6.4.2.5. India market size & forecast, by product
6.4.2.6. India market size & forecast, by end user
6.4.2.7. Australia market size & forecast, by product
6.4.2.8. Australia market size & forecast, by end user
6.4.2.10. Rest of Asia-Pacific market size & forecast, by product
6.4.2.11. Rest of Asia-Pacific market size & forecast, by end user

6.4.3. Asia-Pacific market size & forecast, by product
6.4.4. Asia-Pacific market size & forecast, by end user

6.5. LAMEA

6.5.1. Key trends and opportunities
6.5.2. LAMEA market size & forecast, by country

6.5.2.1. Brazil market size & forecast, by product
6.5.2.2. Brazil market size & forecast, by end user
6.5.2.3. South Africa market size & forecast, by product
6.5.2.4. South Africa market size & forecast, by end user
6.5.2.5. Saudi Arabia market size & forecast, by product
6.5.2.6. Saudi Arabia market size & forecast, by end user
6.5.2.7. Rest of LAMEA market size & forecast, by product
6.5.2.8. Rest of LAMEA market size & forecast, by end user

6.5.3. LAMEA market size & forecast, by product
6.5.4. LAMEA market size & forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Adherium

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Business performance
7.1.5. Key strategic Moves and Development

7.2. AstraZeneca PLC

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Product portfolio
7.2.4. Business performance
7.2.5. Key strategic moves and developments

7.3. Cohero Health, Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Business segment
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments

7.4. GlaxoSmithKline plc

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance

7.5. Health Care Originals

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.5.4. Key strategic Moves and Development

7.6. Koninklijke Philips N.V.,

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. PROPELLER HEALTH

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Key strategic moves and developments

7.8. Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance

7.9. Vectura Group plc

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic Moves and Development

7.10. Volansys Technologies

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio